AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Phase III data for influenza vaccine presented at conference.

Vaccine Weekly

| November 12, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 NOV 12 - (NewsRx.com & NewsRx.net) -- Data from five large studies with an investigational intranasal, cold-adapted trivalent influenza vaccine (CAIV-T) were presented at the Fifth International Options for the Control of Influenza Conference in Okinawa, Japan.

The studies involved nearly 5500 individuals from a wide range of populations, including infants as young as 6 weeks of age, young children in day care settings, adults aged 60 years or older, and healthy adult males from 24 to 45 years of age.

"These data are very encouraging and will be important additions to our ongoing development plans for our next generation intranasal flu vaccine program," said Peter Paradiso, VP, new business, and scientific affairs for Wyeth.

James F. Young, PhD, MedImmune's president, research and development, said, "The cold-adapted flu technology used to manufacture CAIV-T - a liquid, refrigerator-stable formulation - is the same technology used to make the current frozen version of FluMist (Influenza Virus Vaccine Live, Intranasal), which is the first needle-free flu vaccine approved in the United States.

FluMist is currently indicated for healthy people 5-49 years of age. The data presented at the Options conference ...

Related articles from newspapers, magazines, journals, and more
Chiron to Hold Conference Call on Flu Vaccines on Monday, October 17; Company...
Press release article from: Business Wire October 17, 2005 700+ words
...hold an investor conference call on Monday, October 17, at 4:30 p.m. EDT to discuss the return of its FLUVIRIN(R) influenza virus vaccine to the U.S. market and the company's influenza vaccines business outlook. To access either the live conference...
sanofi pasteur Launches New Version of Its Pediatric Influenza Vaccine.
Press release article from: PR Newswire March 9, 2005 700+ words
...Fluzone(R), Influenza Virus Vaccine, No Preservative...only injectable influenza vaccine approved by the...Preservative, Influenza Virus Vaccine as well as the traditional influenza vaccine, Fluzone, Influenza Virus Vaccine, by contacting...
Neuraminidase-deficient influenza virus is potential vaccine vector.
Newspaper article from: Drug Week May 7, 2004 700+ words
...mutant as a live attenuated influenza vaccine, all mice vaccinated with...These results suggest that influenza virus could be a useful vector...the major subject areas of Influenza Vaccine, Influenza Virus, Vaccine Vector, Vector...
Genetic analysis of influenza virus master donor strain reported.
Newspaper article from: Medical Letter on the CDC & FDA July 18, 2004 700+ words
...variants of the ca/ts Len/17 influenza virus," researchers in the United...manufacturing of the cold-adapted influenza vaccine (CAIV), particularly with...areas of Influenza Vaccine, Influenza Virus, Vaccine Efficacy, Vaccine...
Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009...
Press release article from: PR Newswire August 1, 2008 700+ words
...began shipping influenza vaccine (Fluzone(R), Influenza Virus Vaccine) in...million doses of influenza vaccine began shipping...This year's influenza vaccine contains three new strains of the influenza virus, A/Brisbane...
Aventis begins shipping influenza vaccine to providers.
Newspaper article from: BIOTECH Patent News July 1, 2003 700+ words
...shipping its influenza vaccine (Fluzone, Influenza Virus Vaccine) one...largest supplier of influenza vaccine. "Aventis Pasteur...age receiving influenza vaccine for the first...orders for Fluzone Influenza Virus Vaccine and Fluzone...
Medimmune Completes Enrollment in Phase 3 Study Comparing Next-Generation,...
Press release article from: PR Newswire November 1, 2004 700+ words
...T (cold adapted intranasal influenza vaccine, trivalent), to the injectable influenza vaccine. MedImmune is developing CAIV...its currently marketed frozen influenza vaccine, FluMist (Influenza Virus Vaccine Live, Intranasal...
Sanofi pasteur Begins Shipments of Influenza Vaccine.
Press release article from: PR Newswire September 1, 2006 700+ words
...began shipping influenza vaccine (Fluzone(R), Influenza Virus Vaccine) to...is the only influenza vaccine licensed for...Fluzone(R), Influenza Virus Vaccine, No...licensed injectable influenza vaccine to be manufactured...
Aventis Ships First Influenza Vaccine to Health-Care Providers; First vaccine...
Press release article from: PR Newswire August 2, 2004 700+ words
...to ship its influenza vaccine (Fluzone(R), Influenza Virus Vaccine) today...shipments of influenza vaccine this year by...Pediatric Dose, Influenza Virus Vaccine. Health...effects from influenza vaccine are pain and...
Sanofi pasteur Completes Shipment of 50 Million Doses of Influenza Vaccine.
Press release article from: PR Newswire November 27, 2006 700+ words
...million doses of influenza vaccine (Fluzone(R), Influenza Virus Vaccine) to...is the only influenza vaccine licensed for...Fluzone(R), Influenza Virus Vaccine, No...licensed injectable influenza vaccine to be manufactured...
For more facts and information, see all results

Source: HighBeam Research, Phase III data for influenza vaccine presented at conference.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA